Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06533774 · ClinicalTrials.gov registry record · NA
Speech Locator_Benefits in Pediatric Popluations
A NA study, sponsored by Sonova.
- Terminated
- Registry status
- NA
- Development phase
- 27
- Enrollment target
NCT06533774: Clinical Trial NA study, sponsored by Sonova.
NCT06533774 is a NA study that was terminated before completion, run by Sonova. The registered enrollment target is 27 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06533774, a NA study, was terminated before completion, sponsored by Sonova.
- TERMINATED
- Registry status
- NA
- Development phase
- 27 participants
- Enrollment target
Study Summary
The study seeks to evaluate the impact of SpeechSensor and StereoZoom 2.0 on speech understanding in noise in dynamic listening conditions in pediatric hearing aid users.
Primary Outcome
Verbal response accuracy based on percent of words correctly repeated on an open-set sentence recognition in noise task. 1. Initial - Personalized Signal-to-Noise-Ratio (SNR) is determined for each participant by finding the point where the participant scores 50% correct individual words within sentences. The personalized SNR is determined from the average of two list for a given condition. (SpeechSensor and SZ2.0 objectives) 2. For comparison conditions - Speech as noise will be presented at t
Interventions
- DEVICE Phonak Audéo Lumity 90-R
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2023-06-08 |
| Est. Completion | 2023-10-31 |
| Phase | NA |
Why NCT06533774 stopped before completion
NCT06533774 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Phonak Audéo Lumity 90-R is the first listed.
NCT06533774 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06533774 about?
NCT06533774 is a clinical study titled "Speech Locator_Benefits in Pediatric Popluations". The study seeks to evaluate the impact of SpeechSensor and StereoZoom 2.0 on speech understanding in noise in dynamic listening conditions in pediatric hearing aid users.
What is the current status of trial NCT06533774?
This trial is currently terminated. It is a NA study. The enrollment target is 27 participants. The study started on 2023-06-08. Estimated completion is 2023-10-31.
What interventions are being tested in trial NCT06533774?
The interventions under investigation include: Phonak Audéo Lumity 90-R (DEVICE).
Who is sponsoring clinical trial NCT06533774?
This trial is sponsored by Sonova, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06533774's enrollment target sits among peer trials
27 1708th of 2000 higher than 291 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI